BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clover Announces Advance Purchase Agreement with Gavi

Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates to address ...

June 30, 2021 | News

Innovent Announces An Agreement with Synaffix

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medi...

June 29, 2021 | News

The Third Asia Pacific Psychiatry Symposium Takes Place

The global COVID-19 pandemic poses a serious threat to physical health and has wide-ranging implications for mental health worldwide. At the third Asia Pac...

June 29, 2021 | News

Peijia Medical leads China into the "Retrievable Era" using TAVR products

The TaurusElite® Transcatheter Aortic Valve Replacement System (hereinafter referred to as "TaurusElite®") developed by Peijia Medical (9996.H...

June 28, 2021 | News

China's Public Health System Primed for Digital Innovation

China's Public Health System Primed for Digital Innovation Online/Offline Service Delivery 'Huge Growth Opportunity', says Ping An Co-CEO Ms. Tan ...

June 26, 2021 | News

Zuellig Pharma to advance Cyber-intelligence Capabilities

Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture CYFIRMA, a threat discovery and cyb...

June 25, 2021 | News

China's first CAR-T Cell Therapy (FKC876) approved

The first* CAR-T cell therapy approved by NMPA: opening a new era of cell therapy in China Individualized living-cell-based medicine: genetica...

June 24, 2021 | News

Endurance RP A New Perspective Eye on China's fertility and longevity market

Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) is pleased to annou...

June 24, 2021 | News

Chinese Bioheng Biotech received ODD from the U.S. FDA

"CTD401 is the first innovative product based on our next-generation generic CAR-T technology platform. It has excellent efficacy and superior safety in ex...

June 21, 2021 | News

Malaysia Granted Permission for COVID-19 Test Kit from China for Emergency Use

Amid rising concerns about the threat and economic impact of COVID-19, Holista Colltech Limited has been granted permission for Special access under the Me...

June 18, 2021 | News

Antengene continued to execute its dual-engine growth strategy

Announces two new in-house discovered assets - ATG-031, a potential first-in-class anti-CD24 monoclonal antibody, and ATG-027, a potential first-in-class...

June 18, 2021 | News

Chinese Firm Zhongchao Partners with AbbVie Inc.to provide Medical Education Services

("Zhongchao" or the "Company"), a healthcare services company offering online healthcare information, professional training and educational services, today...

June 17, 2021 | News

Harbour BioMed and Dana-Farber to Advance Novel Biotherapies for Cancer Treatment

Harbour BioMed scientists and Dana-Farber researchers will be working together to develop novel oncologic drugs, including bispecific antibodies and CAR-T ...

June 16, 2021 | News

Chinese biotech firm Vazyme to showcase full range of COVID-19 Testing Solutions at Medlab

Medlab has become a world-famous laboratory exhibition and a globally-recognized professional IVD expo with international stature. Last year alone, the eve...

June 15, 2021 | News

Stay Connected